Edition:
United States

Bio Rad Laboratories Inc (BIO.N)

BIO.N on New York Stock Exchange

200.41USD
24 Mar 2017
Change (% chg)

$0.22 (+0.11%)
Prev Close
$200.19
Open
$200.40
Day's High
$203.16
Day's Low
$200.02
Volume
44,232
Avg. Vol
41,509
52-wk High
$209.50
52-wk Low
$132.36

Latest Key Developments (Source: Significant Developments)

Bio Rad Laboratories Inc says expects to achieve long-term currency-neutral revenue growth of approximately 3% to 5%
Monday, 13 Mar 2017 08:31am EDT 

Bio Rad Laboratories Inc : Bio Rad Laboratories Inc says expects to achieve long-term currency-neutral revenue growth of approximately 3% to 5% . Bio Rad Laboratories Inc says expects to achieve currency-neutral EBITDA margin of greater than 20% by 2020 . Bio Rad Laboratories Inc says reiterated its 2017 financial outlook .FY2017 earnings per share view $2.80, revenue view $2.11 billion -- Thomson Reuters I/B/E/S.  Full Article

Bio Rad Laboratories reports Q2 profit $0.61 per share
Wednesday, 3 Aug 2016 04:15pm EDT 

Bio Rad Laboratories Inc : Second-Quarter reported revenues were $516.8 million, an increase of 2.1 percent . Bio-Rad reports second-quarter 2016 financial results .Net income for Q2 of 2016 was $18.0 million, or $0.61 per share.  Full Article

Bio-Rad Laboratories Inc's TANGO infinity Receives FDA 510(k) Clearance for U.S. Markets
Monday, 21 Dec 2015 04:21pm EST 

Bio-Rad Laboratories:Received U.S. Food and Drug Administration clearance to market its TANGO infinity system in the U.S.The system automates routine blood typing and screening testing procedures for patients and donors.  Full Article

Bio-Rad Laboratories Inc announces U.S. FDA pre-market approval for BioPlex 2200 HIV Ag-Ab Assay
Tuesday, 28 Jul 2015 04:15pm EDT 

Bio-Rad Laboratories Inc:Received U.S. Food and Drug Administration pre-market approval to offer its BioPlex 2200 HIV Ag-Ab assay, the company's 5th generation HIV diagnostic test.  Full Article

More From Around the Web

BRIEF-Bio Rad Laboratories management intends to three people for election to its board

* Management intends to propose Jeffrey Edwards, Gregory Hinckley and Arnold Pinkston for election to its board of directors